Bicalutamide (Casodex®) in the treatment
✍
Kolvenbag, Geert J.C.M.; Blackledge, George R.P.; Gotting-Smith, Karen
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 170 KB
👁 1 views
BACKGROUND. Bicalutamide (Casodex) is a new nonsteroidal antiandrogen developed for use in patients with prostate cancer. The efficacy and tolerability of bicalutamide as monotherapy and as combination therapy for patients with advanced prostate cancer have been evaluated in randomized clinical tria